Clinical Trials Update: April 15 2005
COPD (Chronic Obstructive Pulmonary Disease) Generalized Anxiety Disorder (GAD) Metabolic Syndrome
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
COPD (Chronic Obstructive Pulmonary Disease)
Qualified participants for this study must be at least 40 years old. They will receive study-related care and study medication, plus compensation for time and travel. Research site located in West Palm Beach, Fla.
Generalized Anxiety Disorder (GAD)
The purpose of this study is to research different doses of an investigational drug in approximately 350 patients, between the ages 18-65 years old that have a doctor's diagnosis of generalized anxiety disorder. Research sites located throughout the United States.
People with the metabolic syndrome (MeS) are at increased risk of developing cardiovascular disease. This increased risk may, in part, be related to abnormalities in the blood vessels. Research site located in Baltimore, MD.
Copyright 2005 CenterWatch. All rights reserved.